Financial News
Headline News about Capricor Therapeutics, Inc. - Common Stock


Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
September 21, 2024
Via Talk Markets

Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)
September 20, 2024
Via Benzinga


Unveiling 6 Analyst Insights On Capricor Therapeutics
July 02, 2024
Via Benzinga


Expert Ratings For Capricor Therapeutics
May 14, 2024
Via Benzinga

Recap: Capricor Therapeutics Q4 Earnings
February 29, 2024
Via Benzinga


Capricor Therapeutics's Earnings Outlook
February 28, 2024
Via Benzinga

Via Benzinga




Preview: Capricor Therapeutics's Earnings
November 13, 2023
Via Benzinga

FlexShopper And 3 Other Penny Stocks Insiders Are Buying
October 12, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities

Recap: Capricor Therapeutics Q1 Earnings
May 11, 2023
Via Benzinga

Earnings Preview For Capricor Therapeutics
March 14, 2023
Via Benzinga


US Stocks Turn Lower; Dow Tumbles Over 200 Points
September 29, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities


12 Health Care Stocks Moving In Friday's Intraday Session
September 29, 2023
Via Benzinga

Crude Oil Down 1% Following PCE Data; Blue Apron Shares Surge
September 29, 2023
Via Benzinga
Topics
Stocks

Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
September 29, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities

12 Health Care Stocks Moving In Friday's Pre-Market Session
September 29, 2023
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via Benzinga



Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 26, 2022
October 26, 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.